Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction‐Associated Steatohepatitis
PROTEOMICS – Clinical Applications · 2024
DOI: 10.1002/prca.202300236 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, 2024. Verfasst von Achuthan Sourianarayanane und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Biomarkers, Liver, Blood Proteins, Proteomics. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: NIH HHS.
Abstract (Originalsprache)
Background
Biomarkers for metabolic dysfunction‐associated steatohepatitis (MASH) have been considered based on proteomic and lipidomic data from plasma and liver tissue without clinical benefits. This study evaluated proteomics‐based plasma and liver tissue biomarkers collected simultaneously from patients with metabolic dysfunction‐associated steatotic liver disease (MASLD).
Methods
Liver tissue and plasma samples were collected during liver biopsy to diagnose MASLD. Untargeted proteomics was performed on 64 patients.
Results
Twenty plasma proteins were up‐ or downregulated in patients with MASH compared with those without MASH. The potential biomarkers utilizing the best combinations of these plasma proteins had an area under the receiver operating curve (AUROC) of 0.671 for detecting those with MASH compared with those without it. However, none of the 20 plasma proteins were represented among the significantly regulated liver tissue proteins in patients with MASH. Ten of them displayed a trend and relevance in liver tissue with MASLD progression. These 10 plasma proteins had an AUROC of 0.793 for MASH identification and higher positive and negative predictive values.
Conclusion
The plasma and liver protein expressions of patients with MASH were not directly comparable. Plasma protein biomarkers that are also expressed in liver tissue can help improve MASH detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Proteomics Core Facility, UC Davis Genome Center, University of California, Davis, California, USA.
- Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID-Profile: Achuthan Sourianarayanane, Michelle R Salemi, Brett S Phinney
Förderung
- NIH HHS
Zitieren
APA
Sourianarayanane, A., Salemi, M. R., Phinney, B. S., & McCullough, A. J. (2024). Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction‐Associated Steatohepatitis. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.202300236
Vancouver
Sourianarayanane A, Salemi MR, Phinney BS, McCullough AJ. Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction‐Associated Steatohepatitis. PROTEOMICS – Clinical Applications. 2024. doi:10.1002/prca.202300236
BibTeX
@article{Sourianarayanane2024,
author = {Sourianarayanane, Achuthan and Salemi, Michelle R and Phinney, Brett S and McCullough, Arthur J},
title = {Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction‐Associated Steatohepatitis},
journal = {PROTEOMICS – Clinical Applications},
year = {2024},
doi = {10.1002/prca.202300236}
}
EUVIMED